Issue 23, 2015

Ruthenium complexes as inhibitors of human islet amyloid polypeptide aggregation, an effect that prevents beta cell apoptosis

Abstract

Human islet amyloid polypeptide (hIAPP) aggregation is essential in the loss of insulin-producing pancreatic beta cells in type 2 diabetes mellitus (T2DM). Recent studies have identified hIAPP fibril as a therapeutic target of T2DM. Metal complexes could covalently bind to the intracellular peptides to regulate their biological functions. In the present study, ruthenium (Ru) complexes NAMI-A (1) [Ru(bpy)3](ClO4)2 (2) (bpy = 2,2′-dipyridyl), [Ru(pip)3](ClO4)2 (3) (pip = 2-phenylimidazo[4,5-f]-[1,10]phenanthroline) and [Ru(phtpy)(phen)Cl]ClO4 (4) (phtpy = 2,6-bis(2-pyridyl)-4-phenylpyridine, phen = 1,10-phenanthroline) were selected to investigate their influence on hIAPP fibrillation in vitro. The results of thioflavin T (ThT) fluorescence assay showed that Ru complexes effectively inhibited the formation of hIAPP fibril. AFM images and TEM images further validated that the hIAPP fibrillation was disaggregated by the Ru complexes and then formed nanoscale particles, which tends to be a time-dependent process. Moreover, Ru complexes demonstrated a protective effect towards hIAPP-caused cell damage by restraining ROS generation and blocking cell apoptosis. In addition, it has been found that Ru complexes can also disaggregate hIAPP fibrils effectively inside the cells, and that the effects were proportional to the lipophilicity of the Ru complexes. Taken together, this study provides a strategy for designing Ru complexes for treating T2DM by targeting hIAPP.

Graphical abstract: Ruthenium complexes as inhibitors of human islet amyloid polypeptide aggregation, an effect that prevents beta cell apoptosis

Supplementary files

Article information

Article type
Paper
Submitted
25 Dec. 2014
Accepted
19 Janv. 2015
First published
20 Janv. 2015

RSC Adv., 2015,5, 17405-17412

Ruthenium complexes as inhibitors of human islet amyloid polypeptide aggregation, an effect that prevents beta cell apoptosis

L. Ma, Y. Fu, L. Yu, X. Li, W. Zheng and T. Chen, RSC Adv., 2015, 5, 17405 DOI: 10.1039/C4RA15152F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements